Full Text View
Tabular View
No Study Results Posted
Related Studies
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
This study has been completed.
Study NCT00333190.   Last updated on March 13, 2009.
Information provided by Dana-Farber Cancer Institute
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hematologic Malignancy
AML
ALL
CML
Multiple Myeloma
NHL
Hodgkin's Lymphoma
Additional conditions recognized in this trial
Graft vs Host Disease
Hematologic Neoplasms
Hodgkin Disease
Lymphoma
Neoplasms, Plasma Cell
More general conditions related to this trial
Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Paraproteinemias
Vascular Diseases
Interventions listed in this trial
CD+8 T cell depletion
Sponsors listed in this trial
Dana-Farber Cancer Institute
Brigham and Women's Hospital


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services